Goncalves, Marcus D. http://orcid.org/0000-0002-0784-9248
Cantley, Lewis C.
Article History
First Online: 15 July 2020
Competing interests
: L.C.C. is a founder, shareholder and member of the BOD and SAB of Agios Pharmaceuticals. He is also a cofounder and member of the SAB and a shareholder of Petra Pharmaceuticals. Both companies are developing therapies for cancer. The laboratory of L.C.C. also receives financial support from Petra Pharmaceuticals. L.C.C. and M.D.G. are cofounders and shareholders of Faeth Therapeutics, which is developing nutritional therapies for cancer. M.D.G. has received speaking and/or consulting fees from Pfizer Inc., Bayer AG, Novartis AG, Petra Pharmaceuticals and TruMacro nutrition. The laboratory of M.D.G. receives financial support from Pfizer, Inc.